Gifu Red Cross Hospital

Recent papers from Gifu Red Cross Hospital

1. Efficacy of Lenvatinib as Subsequent Therapy After Combination Immune Checkpoint Inhibitors for Unresectable Hepatocellular CarcinomaAnticancer Research · 2026
2. Reply to the Letter to the Editor Regarding “Age and Nocturnal Polyuria in Nocturia: A Multicenter Voiding Diary Cohort Study”Neurourology and Urodynamics · 2026
3. Age and Nocturnal Polyuria in Nocturia: A Multicenter Voiding Diary Cohort StudyNeurourology and Urodynamics · 2026
4. Gemcitabine, Carboplatin, Dexamethasone, and Rituximab Versus High‐Dose Cytarabine‐Based Chemotherapy as Second‐Line Treatments for Relapsed or Refractory Diffuse Large B‐Cell LymphomaHematological Oncology · 2025
5. Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world studyAnnals of Hematology · 2025
6. Five-factor personality traits in patients with schizophrenia and bipolar disorder: A systematic review and meta-analysisThe International Journal of Neuropsychopharmacology · 2025
7. Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R- CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: A real- world study2025
8. The Efficacy of Intradetrusor Onabotulinumtoxin A Injection for Refractory Overactive Bladder Syndrome—A Single-Center Prospective StudyJournal of Clinical Medicine · 2025
9. Hemodialysis patients have lower prevalence of Helicobacter pylori infection: a case–control studyRenal Replacement Therapy · 2025
10. Reproducibility and Screening Capability of Corneal Epithelial Thickness Measurement for Keratoconus Using Anterior Segment Optical Coherence TomographyClinical ophthalmology · 2025
11. Development of Graves' Disease after Resection of an Autonomously Functioning Thyroid NoduleInternal Medicine · 2025
12. Genome-wide association studies for pelvic organ prolapse in the Japanese populationCommunications Biology · 2024
13. Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioningBMC Psychiatry · 2024
14. Viral eradication reduces all‐cause mortality in patients with chronic hepatitis C virus infection who had received direct‐acting antiviral therapyLiver International · 2024
15. Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter studyJGH Open · 2024
16. Effectiveness of onabotulinumtoxin A for refractory overactive bladder with cough‐associated detrusor overactivityIJU Case Reports · 2024
17. A phase II study of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed or refractory non‐Hodgkin lymphomaHematological Oncology · 2023
18. Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly populationScientific Reports · 2023
19. The prevalence and predictive factors of nocturnal polyuria in Japanese patients with nocturia: a multicentral retrospective cohort studyScientific Reports · 2023
20. Evaluation of long-term clinical outcomes after toric implantable collamer lens implantationJournal of Cataract & Refractive Surgery · 2023